Merck to initiate new clinical programme with lower dose of daily oral Islatravir in combination…
Phase-II study evaluating an investigational weekly oral combination treatment regimen of Islatravir and Gilead Sciences’…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
islatravir
Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1…
This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options
Gilead, Merck sign pact to develop, commercialise long-acting HIV treatment combinations
Collaboration to focus on oral and injectable formulations of Lenacapavir and Islatravir